Ausiello Dennis A — SEC Form 4 filings
SEC reporting owner CIK 1381994. 15 Form 4 filings on record with FilingPulse; latest filed 2026-07-10.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-04-08 to 2026-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 2 filings — 51,698 shares, $19,035,122 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: sale of 7,675 shares @ $435.40 ($3,341,695) in ALNYLAM PHARMACEUTICALS, INC., filed 2025-08-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | 5 | — | 18 legs · 51,698 sh · $19,035,122 | 21 |
| Rani Therapeutics Holdings, Inc. (RANI) | Director | 4 | — | — | 7 |
| Seres Therapeutics, Inc. (MCRB) | Director | 6 | — | — | 6 |
Form 4 filings — Ausiello Dennis A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-10 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 7,508 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Rani Therapeutics Holdings, Inc. (RANI) | Grant/award (A): 123,600 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 671 @ $0 · Grant/award (A): 1,441 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Option exercise (M): 9,000 @ $72.01 · Option exercise (M): 5,153 @ $128.31 · Option exercise (M): 4,581 @ $148.77 · Option exercise (M): 5,228 @ $151.22 · Option exercise (M): 4,032 @ $171.95 · Option exercise (M): 3,454 @ $189.87 · +17 more | EDGAR |
| 2025-07-02 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 6,452 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Rani Therapeutics Holdings, Inc. (RANI) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 775 @ $0 · Grant/award (A): 1,558 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Rani Therapeutics Holdings, Inc. (RANI) | Disposition to issuer (D): 101,276 (derivative) · Grant/award (A): 101,276 (derivative) · Disposition to issuer (D): 15,423 (derivative) · Grant/award (A): 15,423 (derivative) | EDGAR |
| 2024-08-08 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Option exercise (M): 11,250 @ $131.21 · Option exercise (M): 9,000 @ $105.26 · Sale (S): 1,627 @ $259.56 · Sale (S): 3,742 @ $260.40 · Sale (S): 6,212 @ $261.63 · Sale (S): 4,367 @ $262.79 · +5 more | EDGAR |
| 2024-07-03 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 64,564 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Rani Therapeutics Holdings, Inc. (RANI) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 5,228 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1381994 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →